Exact Mass: 475.1566
Exact Mass Matches: 475.1566
Found 373 metabolites which its exact mass value is equals to given mass value 475.1566
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
E3040 glucuronide
A member of the class of benzothiazoles that is E3040 in which the hydroxy hydrogen at position 6 has been replaced by a beta-D-glucosiduronic acid group. It is a metabolite of the anti-inflammatory drug, E3040.
Codeine-6-glucuronide
Codeine-6-glucuronide (C6G) is a major active metabolite of codeine and may be responsible for as much as 60\\% of the analgesic effects of codeine. C6G exhibits decreased immunosuppressive effects compared to codeine. During its metabolism, codeine is conjugated with glucuronic acid by the enzyme UDP-Glucuronosyltransferase-2B7 (UGT2B7) to form codeine-6-glucuronide. (Wikipedia) D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids
OA-6129 D
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D013845 - Thienamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Ertapenem
Meropenem in which the one of the two methyl groups attached to the amide nitrogen is replaced by hydrogen while the other is replaced by a 3-carboxyphenyl group. The sodium salt is used for the treatment of moderate to severe susceptible infections including intra-abdominal and acute gynaecological infections, pneumonia, and infections of the skin and of the urinary tract. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DH - Carbapenems D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Pivmecillinam hydrochloride
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Pipotiazine
Pipotiazine has actions similar to those of other phenothiazines. Among the different phenothiazine derivatives, it appears to be less sedating and to have a weak propensity for causing hypotension or potentiating the effects of CNS depressants and anesthetics. However, it produces a high incidence of extra pyramidal reactions. It is used for the maintenance treatment of chronic non-agitated schizophrenic patients. Symptoms of overdose include severe extrapyramidal manifestations, hypotension, lethargy and sedation. N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AC - Phenothiazines with piperidine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
Ertapenem
Ertapenem is only found in individuals that have used or taken this drug. It is a carbapenem antibiotic marketed by Merck as Invanz®. It is structurally very similar to meropenem in that it possess a 1-beta-methyl group. [Wikipedia]The bactericidal activity of ertapenem results from the inhibition of cell wall synthesis and is mediated through ertapenem binding to penicillin binding proteins (PBPs). In Escherichia coli, it has strong affinity toward PBPs 1a, 1b, 2, 3, 4 and 5 with preference for PBPs 2 and 3. Ertapenem is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases. Ertapenem is hydrolyzed by metallo-beta-lactamases. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DH - Carbapenems D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Arzoxifene
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist C1892 - Chemopreventive Agent
TS-943
[(2R,5R)-5-(6-Aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 2-benzoylbenzoate
4-{7-Acetoxy-5-chloro-3-[(1E,3E)-3,5-dimethyl-1,3-heptadien-1-yl]-7-methyl-6,8-dioxo-7,8-dihydro-2(6H)-isoquinolinyl}butanoic acid
5-O-<6-O-(3-Hydroxy-3-methyl-4-carboxybutanoyl)-beta-D-glucopyranosyl>pyridoxine|5-O-[6-O-(3-Hydroxy-3-methyl-4-carboxybutanoyl)-beta-D-glucopyranosyl]pyridoxine
N-trans-feruloyl tyramine-4-O-beta-D-glucopyranoside
4-epi-N-2hydroxyethylazachaetoviridin A|chaetomugilide C
MLS002154128-01!Pivmecillinam hydrochloride32887-03-9
C20H29NO12_2-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-2-phenylacetamide
C25H30ClNO6_2(6H)-Isoquinolinebutanoic acid, 7-(acetyloxy)-5-chloro-3-[(1E,3E)-3,5-dimethyl-1,3-heptadien-1-yl]-7,8-dihydro-7-methyl-6,8-dioxo
4-[7-acetyloxy-5-chloro-3-[(1E,3E)-3,5-dimethylhepta-1,3-dienyl]-7-methyl-6,8-dioxoisoquinolin-2-yl]butanoic acid
Pipotiazine
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AC - Phenothiazines with piperidine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
C25H30ClNO6_2(6H)-Isoquinolinebutanoic acid, 7-(acetyloxy)-5-chloro-3-[(1E,3E)-3,5-dimethyl-1,3-heptadien-1-yl]-7,8-dihydro-7-methyl-6,8-dioxo
Ala Cys Pro Trp
Ala Cys Trp Pro
Ala Asp Asp Arg
Ala Asp Arg Asp
Ala Glu Glu Gln
Ala Glu Gln Glu
Ala Pro Cys Trp
Ala Pro Trp Cys
Ala Gln Glu Glu
Ala Arg Asp Asp
Ala Trp Cys Pro
Ala Trp Pro Cys
Cys Ala Pro Trp
Cys Ala Trp Pro
Cys Cys His Asn
Cys Cys Asn His
Cys Glu Pro Gln
Cys Glu Gln Pro
Cys His Cys Asn
Cys His Asn Cys
Cys Asn Cys His
Cys Asn His Cys
Cys Pro Ala Trp
Cys Pro Glu Gln
Cys Pro Gln Glu
Cys Pro Trp Ala
Cys Gln Glu Pro
Cys Gln Pro Glu
Cys Trp Ala Pro
Cys Trp Pro Ala
Asp Ala Asp Arg
Asp Ala Arg Asp
Asp Asp Ala Arg
Asp Asp Ile Asn
Asp Asp Leu Asn
Asp Asp Asn Ile
Asp Asp Asn Leu
Asp Asp Gln Val
Asp Asp Arg Ala
Asp Asp Val Gln
Asp Glu Gly Arg
Asp Glu Asn Val
Asp Glu Arg Gly
Asp Glu Val Asn
Asp Gly Glu Arg
Asp Gly Arg Glu
Asp Ile Asp Asn
Asp Ile Asn Asp
Asp Leu Asp Asn
Asp Leu Asn Asp
Asp Met Asn Pro
Asp Met Pro Asn
Asp Asn Asp Ile
Asp Asn Asp Leu
Asp Asn Glu Val
Asp Asn Ile Asp
Asp Asn Leu Asp
Asp Asn Met Pro
Asp Asn Asn Asn
Asp Asn Pro Met
Asp Asn Val Glu
Asp Pro Met Asn
Asp Pro Asn Met
Asp Gln Asp Val
Asp Gln Val Asp
Asp Arg Ala Asp
Asp Arg Asp Ala
Asp Arg Glu Gly
Asp Arg Gly Glu
Asp Val Asp Gln
Asp Val Glu Asn
Asp Val Asn Glu
Asp Val Gln Asp
Glu Ala Glu Gln
Glu Ala Gln Glu
Glu Cys Pro Gln
Glu Cys Gln Pro
Glu Asp Gly Arg
Glu Asp Asn Val
Glu Asp Arg Gly
Glu Asp Val Asn
Glu Glu Ala Gln
Glu Glu Gln Ala
Glu Gly Asp Arg
Glu Gly Arg Asp
Glu Asn Asp Val
Glu Asn Val Asp
Glu Pro Cys Gln
Glu Pro Gln Cys
Glu Gln Ala Glu
Glu Gln Cys Pro
Glu Gln Glu Ala
Glu Gln Pro Cys
Glu Arg Asp Gly
Glu Arg Gly Asp
Glu Val Asp Asn
Glu Val Asn Asp
Gly Asp Glu Arg
Gly Asp Arg Glu
Gly Glu Asp Arg
Gly Glu Arg Asp
Gly Arg Asp Glu
Gly Arg Glu Asp
His Cys Cys Asn
His Cys Asn Cys
His Asn Cys Cys
Ile Asp Asp Asn
Ile Asp Asn Asp
Ile Asn Asp Asp
Leu Asp Asp Asn
Leu Asp Asn Asp
Leu Asn Asp Asp
Met Asp Asn Pro
Met Asp Pro Asn
Met Asn Asp Pro
Met Asn Pro Asp
Met Pro Asp Asn
Met Pro Asn Asp
Asn Cys Cys His
Asn Cys His Cys
Asn Asp Asp Ile
Asn Asp Asp Leu
Asn Asp Glu Val
Asn Asp Ile Asp
Asn Asp Leu Asp
Asn Asp Met Pro
Asn Asp Asn Asn
Asn Asp Pro Met
Asn Asp Val Glu
Asn Glu Asp Val
Asn Glu Val Asp
Asn His Cys Cys
Asn Ile Asp Asp
Asn Leu Asp Asp
Asn Met Asp Pro
Asn Met Pro Asp
Asn Asn Asp Asn
Asn Asn Asn Asp
Asn Asn Gln Thr
Asn Asn Thr Gln
Asn Pro Asp Met
Asn Pro Met Asp
Asn Gln Asn Thr
Asn Gln Gln Ser
Asn Gln Ser Gln
Asn Gln Thr Asn
Asn Ser Gln Gln
Asn Thr Asn Gln
Asn Thr Gln Asn
Asn Val Asp Glu
Asn Val Glu Asp
Pro Ala Cys Trp
Pro Ala Trp Cys
Pro Cys Ala Trp
Pro Cys Glu Gln
Pro Cys Gln Glu
Pro Cys Trp Ala
Pro Asp Met Asn
Pro Asp Asn Met
Pro Glu Cys Gln
Pro Glu Gln Cys
Pro Met Asp Asn
Pro Met Asn Asp
Pro Asn Asp Met
Pro Asn Met Asp
Pro Gln Cys Glu
Pro Gln Glu Cys
Pro Trp Ala Cys
Pro Trp Cys Ala
Gln Ala Glu Glu
Gln Cys Glu Pro
Gln Cys Pro Glu
Gln Asp Asp Val
Gln Asp Val Asp
Gln Glu Ala Glu
Gln Glu Cys Pro
Gln Glu Glu Ala
Gln Glu Pro Cys
Gln Asn Asn Thr
Gln Asn Gln Ser
Gln Asn Ser Gln
Gln Asn Thr Asn
Gln Pro Cys Glu
Gln Pro Glu Cys
Gln Gln Asn Ser
Gln Gln Ser Asn
Gln Ser Asn Gln
Gln Ser Gln Asn
Gln Thr Asn Asn
Gln Val Asp Asp
Arg Ala Asp Asp
Arg Asp Ala Asp
Arg Asp Asp Ala
Arg Asp Glu Gly
Arg Asp Gly Glu
Arg Glu Asp Gly
Arg Glu Gly Asp
Arg Gly Asp Glu
Arg Gly Glu Asp
Ser Asn Gln Gln
Ser Gln Asn Gln
Ser Gln Gln Asn
Thr Asn Asn Gln
Thr Asn Gln Asn
Thr Gln Asn Asn
Val Asp Asp Gln
Val Asp Glu Asn
Val Asp Asn Glu
Val Asp Gln Asp
Val Glu Asp Asn
Val Glu Asn Asp
Val Asn Asp Glu
Val Asn Glu Asp
Val Gln Asp Asp
Trp Ala Cys Pro
Trp Ala Pro Cys
Trp Cys Ala Pro
Trp Cys Pro Ala
Trp Pro Ala Cys
Trp Pro Cys Ala
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclohexylamino)-2-oxoethyl]-N-(2-fluorophenyl)-7-methyl- (9CI)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclohexylamino)-2-oxoethyl]-N-(4-fluorophenyl)-7-methyl- (9CI)
TERT-BUTYL 4-(4-(2-BROMOBENZYL)PIPERAZIN-1-YL)-3-NITROBENZOATE
4-(5-(3,5-DIMETHYLISOXAZOL-4-YL)THIOPHEN-2-YL)-5-METHYL-N-(4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)PYRIMIDIN-2-AMINE
2-[ethyl[4-[(6-nitrobenzothiazol-2-yl)azo]phenyl]amino]ethyl benzoate
Trelagliptin succinate
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
Phenyl N-Benzyl-2-amino-4,6-O-benzylidene-2-N,3-O-carbonyl-2-deoxy-1-thio-beta-D-glucopyranoside
Atevirdine mesylate
C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent
N-[[4-[[(4-aminoquinazolin-2-yl)amino]methyl]cyclohexyl]methyl]naphthalene-1-sulfonamide
D019440 - Anti-Obesity Agents > D001067 - Appetite Depressants
N-caffeoyl O-methyltyramine-4-O-beta-D-glucopyranoside
[(2R,5R)-5-(6-Aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 2-benzoylbenzoate
Selexid
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Asn-Leu-Asp-Asp
A tetrapeptide composed of L-asparagine, L-leucine and two L-aspartic acid units joined in sequence by peptide linkages.
4-(3,4-dihydro-1H-isoquinolin-2-ylmethyl)-N-[4-(1-pyrrolidinylsulfonyl)phenyl]benzamide
2-(4-methoxyphenyl)-N-[4-[5-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide
N-[4-(1,3-benzoxazol-2-yl)phenyl]-4-(1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl)benzamide
3-L-lysyl-AMP
An L-lysyl ester obtained by formal condensation of the carboxy group of L-lysine with the 3-hydroxy group of AMP.
3-L-glutaminyl-AMP
An L-glutaminyl derivative that is the ester obtained by formal condensation of the carboxy group of L-glutamine with the 3-hydroxy group of AMP.
N(6)-(5-adenylyl)-L-lysine
An L-lysine derivative that is the phosphoramidate obtained by formal condensation of the phosphate group of AMP with the side-chain amino group of L-lysine.
2-[(7-methoxy-4-methyl-[1,2,4]triazolo[4,3-a]quinolin-1-yl)thio]-N-methyl-N-(4-phenyl-2-thiazolyl)acetamide
2-O-acetylbulbisine Trifluoroacetic acid
A natural product found in Crinum asiaticum var. sinicum.
1-O-acetylbulbisine Trifluoroacetic acid
A natural product found in Crinum asiaticum var. sinicum.
2-methoxy-17-oxoestra-1,3,5(10)-trien-3-yl beta-D-glucopyranosiduronate
4-methoxy-17-oxoestra-1,3,5(10)-trien-3-yl beta-D-glucopyranosiduronate
N-[5-(4-morpholinylsulfonyl)-2-(1-pyrrolidinyl)phenyl]-4,5,6,7-tetrahydro-1-benzothiophene-2-carboxamide
4-[(3aR,4S,9bR)-4-(hydroxymethyl)-1-(2-methoxyphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2S,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2S,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-1-methyl-4-imidazolesulfonamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-1-methyl-4-imidazolesulfonamide
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2R,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-1-methyl-4-imidazolesulfonamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-1-methylimidazole-4-sulfonamide
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2R,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
(3R)-4-(3-bromophenyl)-3-(2-hydroxyethyl)-2-[oxo-(propan-2-ylamino)methyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxylic acid ethyl ester
4-[(3aR,4R,9bR)-4-(hydroxymethyl)-1-(2-methoxyphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
N,N-dimethyl-4-[4-[(1R,5S)-3-(phenylmethyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzamide
N,N-dimethyl-4-[4-[(1S,5R)-3-(4-methylphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzamide
[(1S)-2-[(4-chlorophenyl)methyl]-7-methoxy-1-methylsulfonyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2R,3S,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2S,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2R,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2S,3S,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-1-methyl-4-imidazolesulfonamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-1-methyl-4-imidazolesulfonamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-1-methyl-4-imidazolesulfonamide
(3S)-4-(3-bromophenyl)-3-(2-hydroxyethyl)-2-[oxo-(propan-2-ylamino)methyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxylic acid ethyl ester
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(pyridin-4-yl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide
4-[(3aS,4S,9bS)-4-(hydroxymethyl)-1-(2-methoxyphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
4-[(3aS,4R,9bS)-4-(hydroxymethyl)-1-(2-methoxyphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
N,N-dimethyl-3-[4-[(1R,5S)-6-(phenylmethyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzamide
N,N-dimethyl-3-[4-[(1R,5S)-3-(2-methylphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzamide
[(1R)-2-[(4-chlorophenyl)methyl]-7-methoxy-1-methylsulfonyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
N-[(2S)-2-morpholin-4-yl-2-thiophen-2-ylethyl]-6-phenyl-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide
Codeine-6-glucuronide
D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids
(2S,3S,5R,6R)-3-[2-[3-[[(2R)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-6-(1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D013845 - Thienamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
2-methoxyestrone 3-O-(beta-D-glucuronide)(1-)
A steroid glucuronide anion that is the conjugate base of 2-methoxyestrone 3-O-(beta-D-glucuronide) arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
Buloxibutid
Buloxibutid (AT2 receptor agonist C21) is a agentlike selective angiotensin II AT2 receptor agonist with Ki values of 0.4 nM and >10 μM for the AT2 receptor and AT1 receptor, respectively[1].